RMAM
MBOT icon

Raab & Moskowitz Asset Management’s Microbot Medical MBOT Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 370
2019
Q4 		$0 Buy
+1
New +$6 ﹤0.01% 555
2015
Q1 		– Hold
0
– – – 274
2014
Q4 		– Hold
0
– – – 490

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Raab & Moskowitz Asset Management's MBOT Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of Microbot Medical (MBOT) in Q1 2020, closing a stake of 1 share.

Raab & Moskowitz Asset Management first reported a position in MBOT in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 29 funds tracked by Wall St. Rank hold MBOT as of Q1 2020.

  • Raab & Moskowitz Asset Management reported no remaining Microbot Medical position as of Q1 2020 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 1 Microbot Medical share in Q1 2020.
  • Raab & Moskowitz Asset Management first reported a position in Microbot Medical in Q4 2019 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's Microbot Medical position peaked at $0 in Q4 2019.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.